mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.02 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |